HOME >> MEDICINE >> NEWS
Inflammatory pain may help deter inflammatory diseases like arthritis

Pain alerts the body to danger, but UC San Francisco researchers report that it may play another crucial role - helping to prevent the body from slipping into the chronic inflammation associated with such diseases as arthritis, colitis and asthma.

The finding, published in the September issue of Nature Medicine, provides the first evidence -- after years of inquiry -- of an active process controlling inflammation, and may open a new window to understanding the mechanisms at the heart of chronic inflammatory diseases.

People experience pain when signals from specialized nerve fibers are activated. These pain nerve fibers are triggered when tissue is damaged. They are re-activated by inflammation, the body's normally beneficial response to trauma and infection.

Inflammation increases blood flow to the site of injury and sends in a flood of rescue factors - such as substances that clot wounds and white blood cells that chew up invading disease-causing pathogens -to the site. But research has shown that unrestrained inflammation can cause chronic, debilitating diseases.

Traditionally, researchers have thought that the factors involved in the inflammatory response ultimately dissipated on their own. But the UCSF study suggests that activated pain nerve fibers, themselves, dampen the inflammatory response's first line of attack -- a cell known as the neutrophil, which sweeps into an injured site, releasing chemicals that work to heal wounds.

"Our work suggests that pain acts as a negative feedback control of inflammation," said the lead author of the study, Holly Strausbaugh, PhD, a postdoctoral fellow in the NIH Pain Center at UCSF. "Once enough inflammation builds up that pain nerve fibers are activated, the inflammatory response begins to diminish. Failure of this mechanism could contribute to the development of chronic inflammatory disease."

Notably, said Strausbaugh, pain fibers are not activated until the inflammatory response is we
'"/>

Contact: Jennifer O'Brien
jobrien@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
30-Aug-1999


Page: 1 2 3 4

Related medicine news :

1. Inflammatory cells highly promising target in NF 1
2. Inflammatory marker may be early sign of blood vessel blockages
3. New Anti-Inflammatory Drug Is Easy On The Stomach
4. Specific test key to determine whether or not allergy symptoms are really allergy-related
5. Age should not be a factor in determining heart transplantation eligibility, researchers say
6. Sequential MDCT sufficient for determining possible risk of coronary artery disease
7. Study determines commonly used contrast agent safe for universal use in CT
8. MDCT angiography can potentially help determine which patients are at greater risk of stroke
9. PITT, OHSU: When early life stress occurs determines its impact later
10. Blood pressure drugs may slow deterioration of Alzheimers
11. Parkinsons caregivers at risk for deteriorating health

Post Your Comments:
(Date:4/25/2015)... Providenciales, Turks and Caicos Islands, BWI (PRWEB) April 25, ... Providenciales International Airport (PLS) has celebrated three months of ... since reopening on January 5, 2015. , As ... phases, the interior of Providenciales airport was completely redesigned ... area has quickened up the process of getting out ...
(Date:4/25/2015)... April 25, 2015 On Friday, April ... RFID Journal’s annual Best Implementation Award. This award ... the best use of RFID technology to improve its ... the company that best demonstrates how RFID is delivering ... at RFID Journal Live! 2015 in San Diego, the ...
(Date:4/24/2015)... AK (PRWEB) April 24, 2015 As ... (#MOTMC2015) and the unique sacrifices of these young men ... for Service members, Veterans and their Families” presents a ... training is designed to gain a better understanding of ... health and wellness. For those – civilian and military ...
(Date:4/24/2015)... The 1975 have had an intense ... globe to theaters, festivals and TV performances. Now that they’ve ... their label, Dirty Hit Records, to provide clean drinking water ... launched Cadence & Cause website, this four-piece has ... and a signed photo card. Entries from this sweepstakes ...
(Date:4/24/2015)... Anchor Health Administrators (Anchor), specialists in Long-Term ... their exclusive agreement with LTC Solutions for All LLC ... partner. , Anchor has more than 18 years of ... associations, and is currently the designated advocate for the ... Insurance member benefit. , “I am very pleased to ...
Breaking Medicine News(10 mins):Health News:The Tuscany on Grace Bay Celebrates Providenciales Airport Expansion With Summer Specials to Travelers! 2Health News:Seeonic’s Industry Leading Technology Powers Interstate Batteries to Winning Award 2Health News:Coalition Presents Resiliency Training to Raise Awareness during Month of the Military Child (#MOTMC2015) 2Health News:Internationally Recognized British Indie Rock Outfit The 1975 Partner with Cadence & Cause to Provide Clean Drinking Water to Those in Need 2
(Date:4/24/2015)... , April 24, 2015  Lannett Company, Inc. (NYSE: ... and increased its five-year revolving credit facility to $120 ... accordion feature that will allow the company to increase ... $30.0 million, subject to securing additional commitments from existing ... the credit facility remains December 18, 2018.   ...
(Date:4/24/2015)... 2015 Hospira, Inc. (NYSE: ... biosimilar therapies, spoke about the importance of extrapolation in ... Association (EGA) annual European Biosimilars Group conference in ... announced the publication of a pivotal white paper titled, ... promise of biosimilars." Speaking at the ...
(Date:4/24/2015)... April 24, 2015  Blueprint Medicines today announced ... and potent inhibitor of fibroblast growth factor receptor ... of hepatocellular carcinoma (HCC) that are dependent on ... induced complete tumor regression in a subset of ... at the highest dose levels. These data will ...
Breaking Medicine Technology:Lannett Expands Revolving Credit Facility To $120 Million 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 2Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 3Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 4Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 5Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 6Hospira Leadership Presents at Preeminent European Biosimilars Forum, Announces New White Paper on Extrapolation 7Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 2Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma 3
Cached News: